5/16
10:31 am
ogn
Nexstar Media and ASGN have been highlighted as Zacks Bull and Bear of the Day [Yahoo! Finance]
Low
Report
Nexstar Media and ASGN have been highlighted as Zacks Bull and Bear of the Day [Yahoo! Finance]
5/14
02:01 pm
ogn
Surging Earnings Estimates Signal Upside for Organon (OGN) Stock [Yahoo! Finance]
Low
Report
Surging Earnings Estimates Signal Upside for Organon (OGN) Stock [Yahoo! Finance]
5/13
08:43 am
ogn
Best Value Stocks to Buy for May 13th [Yahoo! Finance]
Low
Report
Best Value Stocks to Buy for May 13th [Yahoo! Finance]
5/8
09:28 am
ogn
Organon Q1 Earnings: Does The $1 Billion Debt Offering Signal Trouble? [Seeking Alpha]
Low
Report
Organon Q1 Earnings: Does The $1 Billion Debt Offering Signal Trouble? [Seeking Alpha]
5/7
08:20 pm
ogn
Organon Announces Pricing of $1.0 Billion Senior Notes Offering
Low
Report
Organon Announces Pricing of $1.0 Billion Senior Notes Offering
5/7
07:58 am
ogn
Organon Announces Proposed $1.0 Billion Senior Notes Offering
Neutral
Report
Organon Announces Proposed $1.0 Billion Senior Notes Offering
5/3
01:32 pm
ogn
Organon & Co. (NYSE: OGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $18.00 to $20.00. They now have a "neutral" rating on the stock.
Low
Report
Organon & Co. (NYSE: OGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $18.00 to $20.00. They now have a "neutral" rating on the stock.
5/3
12:53 pm
ogn
Organon & Co. (NYSE:OGN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Organon & Co. (NYSE:OGN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/2
01:42 pm
ogn
What Makes Organon (OGN) a New Buy Stock [Yahoo! Finance]
Low
Report
What Makes Organon (OGN) a New Buy Stock [Yahoo! Finance]
5/2
07:30 am
ogn
Organon Reports Results for the First Quarter Ended March 31, 2024
Neutral
Report
Organon Reports Results for the First Quarter Ended March 31, 2024
5/1
12:32 pm
ogn
Organon (OGN) Gears Up to Report Q1 Earnings: What's in Store? [Yahoo! Finance]
Low
Report
Organon (OGN) Gears Up to Report Q1 Earnings: What's in Store? [Yahoo! Finance]
4/29
10:50 am
ogn
Stay Ahead of the Game With Organon (OGN) Q1 Earnings: Wall Street's Insights on Key Metrics [Yahoo! Finance]
Low
Report
Stay Ahead of the Game With Organon (OGN) Q1 Earnings: Wall Street's Insights on Key Metrics [Yahoo! Finance]
4/29
08:03 am
ogn
Organon & Co. (NYSE: OGN) had its price target raised by analysts at Piper Sandler from $22.00 to $24.00. They now have an "overweight" rating on the stock.
Low
Report
Organon & Co. (NYSE: OGN) had its price target raised by analysts at Piper Sandler from $22.00 to $24.00. They now have an "overweight" rating on the stock.
4/24
07:25 pm
ogn
Organon (OGN) Surpasses Market Returns: Some Facts Worth Knowing [Yahoo! Finance]
Low
Report
Organon (OGN) Surpasses Market Returns: Some Facts Worth Knowing [Yahoo! Finance]
4/22
07:59 pm
ogn
Organon (OGN) Beats Stock Market Upswing: What Investors Need to Know [Yahoo! Finance]
Medium
Report
Organon (OGN) Beats Stock Market Upswing: What Investors Need to Know [Yahoo! Finance]
4/15
07:59 pm
ogn
Organon (OGN) Advances While Market Declines: Some Information for Investors [Yahoo! Finance]
Low
Report
Organon (OGN) Advances While Market Declines: Some Information for Investors [Yahoo! Finance]
4/8
07:52 pm
ogn
Why the Market Dipped But Organon (OGN) Gained Today [Yahoo! Finance]
Low
Report
Why the Market Dipped But Organon (OGN) Gained Today [Yahoo! Finance]
4/8
06:15 am
ogn
Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024
Low
Report
Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024
4/8
06:00 am
ogn
Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoints
Low
Report
Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoints
3/14
06:52 pm
ogn
Markets Dip but it's Time to Buy These Low-Risk High-Income Stocks [Yahoo! Finance]
Low
Report
Markets Dip but it's Time to Buy These Low-Risk High-Income Stocks [Yahoo! Finance]
3/12
12:11 pm
ogn
Here's Why You Should Add Cigna (CI) Stock to Your Portfolio [Yahoo! Finance]
Low
Report
Here's Why You Should Add Cigna (CI) Stock to Your Portfolio [Yahoo! Finance]
2/27
11:22 am
ogn
Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue? [Yahoo! Finance]
Low
Report
Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue? [Yahoo! Finance]
2/20
10:58 am
ogn
Organon & Co. (NYSE: OGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $16.00 to $18.00. They now have a "neutral" rating on the stock.
Low
Report
Organon & Co. (NYSE: OGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $16.00 to $18.00. They now have a "neutral" rating on the stock.
2/20
08:00 am
ogn
Organon Announces HADLIMA™ (adalimumab-bwwd) Has Been Exclusively Selected by the US Department of Veterans Affairs (VA), Replacing HUMIRA on Its National Formulary
Low
Report
Organon Announces HADLIMA™ (adalimumab-bwwd) Has Been Exclusively Selected by the US Department of Veterans Affairs (VA), Replacing HUMIRA on Its National Formulary